Oct
2026
Fiera Milano, Italy
Visit us
stand 8S41, Start-Up Market

Bioworkshops

Exhibitor at CPHI Milan 2026
About Us

Bioworkshops is a full-service CDMO specializing in antibody products and biosimilars. Our services include development and cGMP manufacturing of drug substance and final product:

  • cell lines
  • process development
  • analytical methods
  • formulation
  • process characterization/validation
  • 13,000L of single-use cell culture capacity (200L to 2000L)
  • 3 aseptic filling lines (vials, lyophilized, PFS/Cartridges) up to 100,000 units/batch
  • product testing
  • CTD dossiers
We have over 50 biosimilar cell lines in development.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Start-up
Primary activities
Biopharmaceutical
View company profile
Contact info
  • +86-15618259078
  • No. 5, Dongwang Road,, Suzhou Industrial Park, Suzhou, China
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 8S41, Start-Up Market

Products Featured at CPHI Milan 2026

  • Adalimumab

    Product Adalimumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Anifrolumab

    Product Anifrolumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Atezolizumab

    Product Atezolizumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Bamlanivimab

    Product Bamlanivimab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Bebtelovimab

    Product Bebtelovimab

    Target: SARS-CoV-2 S protein CAS: 2578319-11-4

Bioworkshops Resources (1)